|
1
|
Dinarello CA: The interleukin-1 family: 10
years of discovery. FASEB J. 8:1314–1325. 1994.PubMed/NCBI
|
|
2
|
Lotz M, Blanco FJ, von Kempis J, Dudler J,
Maier R, Villiger PM and Geng Y: Cytokine regulation of chondrocyte
functions. J Rheumatol Suppl. 43:104–108. 1995.PubMed/NCBI
|
|
3
|
van den Berg WB, Joosten LA and van de Loo
FA: TNF alpha and IL-1 beta are separate targets in chronic
arthritis. Clin Exp Rheumatol. 17(6 Suppl 18): S105–S114.
1999.PubMed/NCBI
|
|
4
|
Luo L, Cruz T and McCulloch C: Interleukin
1-induced calcium signalling in chondrocytes requires focal
adhesions. Biochem J. 324:653–658. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pritchard S and Guilak F: Effects of
interleukin-1 on calcium signaling and the increase of filamentous
actin in isolated and in situ articular chondrocytes. Arthritis
Rheum. 54:2164–2174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hubbard JR, Steinberg JJ, Bednar MS and
Sledge CB: Effect of purified human interleukin-1 on cartilage
degradation. J Orthop Res. 6:180–187. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kahle P, Saal JG, Schaudt K, Zacher J,
Fritz P and Pawelec G: Determination of cytokines in synovial
fluids: correlation with diagnosis and histomorphological
characteristics of synovial tissue. Ann Rheum Dis. 51:731–734.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Apte RN and Voronov E: Is interleukin-1 a
good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol
Rev. 222:222–241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McNulty AL, Rothfusz NE, Leddy HA and
Guilak F: Synovial fluid concentrations and relative potency of
interleukin-1 alpha and beta in cartilage and meniscus degradation.
J Orthop Res. 31:1039–1045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Henderson B and Pettipher ER:
Arthritogenic actions of recombinant IL-1 and tumor necrosis factor
alpha in the rabbit: evidence for synergistic interactions between
cytokines in vivo. Clin Exp Immunol. 75:306–310. 1989.PubMed/NCBI
|
|
11
|
Smith AJ, Keen LJ, Billingham MJ, Perry
MJ, Elson CJ, Kirwan JR, Sims JE, Doherty M, Spector TD and Bidwell
JL: Extended haplotypes and linkage disequilibrium in the
IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee
osteoarthritis. Genes Immun. 5:451–460. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valdes AM and Spector TD: The contribution
of genes to osteoarthritis. Rheum Dis Clin North Am. 34:581–603.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Valdes AM and Spector TD: Genetic
epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol.
7:23–32. 2011. View Article : Google Scholar
|
|
14
|
Pillai RS: MicroRNA function: multiple
mechanisms for a tiny RNA? RNA. 11:1753–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wiemer EA: The role of microRNAs in
cancer: no small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen K, Song F, Calin GA, Wei Q, Hao X and
Zhang W: Polymorphisms in microRNA targets: a gold mine for
molecular epidemiology. Carcinogenesis. 29:1306–1311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin
Y, Wang E, Wu M and Shen SH: Aberrant allele frequencies of the
SNPs located in microRNA target sites are potentially associated
with human cancers. Nucleic Acids Res. 35:4535–4541. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saunders MA, Liang H and Li WH: Human
polymorphism at microRNAs and microRNA target sites. Proc Natl Acad
Sci USA. 104:3300–3305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chin LJ, Ratner E, Leng S, Zhai R, Nallur
S, Babar I, Muller RU, Straka E, Su L, Burki EA, et al: A SNP in a
let-7 microRNA complementary site in the KRAS 3′untranslated region
increases non-small cell lung cancer risk. Cancer Res.
68:8535–8540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Landi D, Gemignani F, Naccarati A, Pardini
B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian
F and Landi S: Polymorphisms within micro-RNA-binding sites and
risk of sporadic colorectal cancer. Carcinogenesis. 29:579–584.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brendle A, Lei H, Brandt A, Johansson R,
Enquist K, Henriksson R, Hemminki K, Lenner P and Försti A:
Polymorphisms in predicted microRNA-binding sites in integrin genes
and breast cancer: ITGB4 as prognostic marker. Carcinogenesis.
29:1394–1399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang G, van der Walt JM, Mayhew G, Li YJ,
Züchner S, Scott WK, Martin ER and Vance JM: Variation in the
miRNA-433 binding site of FGF20 confers risk for Parkinson disease
by overex-pression of alpha-synuclein. Am J Hum Genet. 82:283–289.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sethupathy P, Borel C, Gagnebin M, Grant
GR, Deutsch S, Elton TS, Hatzigeorgiou AG and Antonarakis SE: Human
microRNA-155 on chromosome 21 differentially interacts with its
polymorphic target in the AGTR1 3′ untranslated region: a mechanism
for functional single-nucleotide polymorphisms related to
phenotypes. Am J Hum Genet. 81:405–413. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Clop A, Marcq F, Takeda H, Pirottin D,
Tordoir X, Bibé B, Bouix J, Caiment F, Elsen JM, Eychenne F, et al:
A mutation creating a potential illegitimate microRNA target site
in the myostatin gene affects muscularity in sheep. Nat Genet.
38:813–818. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martin MM, Buckenberger JA, Jiang J,
Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD and Elton
TS: The human angiotensin II type 1 receptor +1166 A/C polymorphism
attenuates microRNA-155 binding. J Biol Chem. 282:24262–24269.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu
Y, Guo B, Shen Y, Landi D, et al: An insertion/deletion
polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′
untranslated region confers risk for hepatocellular carcinoma.
Carcinogenesis. 30:2064–2069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fermor B, Jeffcoat D, Hennerbichler A,
Pisetsky DS, Weinberg JB and Guilak F: The effects of cyclic
mechanical strain and tumor necrosis factor alpha on the response
of cells of the meniscus. Osteoarthritis Cartilage. 12:956–962.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuettner KE, Pauli BU, Gall G, Memoli VA
and Schenk RK: Synthesis of cartilage matrix by mammalian
chondrocytes in vitro. 1 Isolation, culture characteristics and
morphology. J Cell Biol. 93:743–750. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maroudas A and Evans H: A study of ionic
equilibria in cartilage. Connect Tissue Res. 1:69–77. 1972.
View Article : Google Scholar
|
|
30
|
Dayer JM, Krane SM, Russell RG and
Robinson DR: Production of collagenase and prostaglandins by
isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci
USA. 73:945–949. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Attur M, Wang HY, Kraus VB, Bukowski JF,
Aziz N, Krasnokutsky S, Samuels J, Greenberg J, McDaniel G,
Abramson SB and Kornman KS: Radiographic severity of knee
osteoarthritis is conditional on interleukin 1 receptor antagonist
gene variations. Ann Rheum Dis. 69:856–861. 2010. View Article : Google Scholar :
|
|
32
|
Dinarello CA: Biologic basis for
interleukin-1 in disease. Blood. 87:2095–2147. 1996.PubMed/NCBI
|
|
33
|
O'Neill LA and Greene C: Signal
transduction pathways activated by the IL-1 receptor family:
ancient signaling machinery in mammals, insects, and plants. J
Leukoc Biol. 63:650–657. 1998.PubMed/NCBI
|
|
34
|
Arner EC, Hughes CE, Decicco CP, Caterson
B and Tortorella MD: Cytokine-induced cartilage proteoglycan
degradation is mediated by aggrecanase. Osteoarthritis Cartilage.
6:214–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fosang AJ, Last K, Knäuper V, Murphy G and
Neame PJ: Degradation of cartilage aggrecan by collagenase-3
(MMP-13). FEBS Lett. 380:17–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Westacott CI, Taylor G, Atkins R and Elson
C: Interleukin 1 alpha and beta production by cells isolated from
membranes around aseptically loose total joint replacements. Ann
Rheum Dis. 51:638–642. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Elson CJ, Mortuza FY, Perry MJ, Warnock
MG, Webb GR and Westacott CI: Cytokines and focal loss of cartilage
in osteoarthritis. Br J Rheumatol. 37:106–107. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Towle CA, Hung HH, Bonassar LJ, Treadwell
BV and Mangham DC: Detection of interleukin-1 in the cartilage of
patients with osteoarthritis: a possible autocrine/paracrine role
in pathogenesis. Osteoarthritis Cartilage. 5:293–300. 1997.
View Article : Google Scholar
|
|
39
|
Moos V, Rudwaleit M, Herzog V, Höhlig K,
Sieper J and Müller B: Association of genotypes affecting the
expression of interleukin-1beta or interleukin-1 receptor
antagonist with osteoarthritis. Arthritis Rheum. 43:2417–2422.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ismaiel S, Atkins RM, Pearse MF, Dieppe PA
and Elson CJ: Susceptibility of normal and arthritic human
articular cartilage to degradative stimuli. Br J Rheumatol.
31:369–373. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Martel-Pelletier J, McCollum R, DiBattista
J, Faure MP, Chin JA, Fournier S, Sarfati M and Pelletier JP: The
interleukin-1 receptor in normal and osteoarthritic human articular
chondrocytes. Identification as the type I receptor and analysis of
binding kinetics and biologic function. Arthritis Rheum.
35:530–540. 1992. View Article : Google Scholar : PubMed/NCBI
|
